INSTITUTE OF CANCER RESEARCH - ROYAL CANCER HOSPITAL - United Kingdom 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 5
As coordinator: 2
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 1*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2014 231.283 0 231.283 1
2013 200.000 3.313.022 387.879 2 1
2010 0 10.499.999 90.716 1

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
KAROLINSKA INSTITUTE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
ACADEMISCH ZIEKENHUIS LEIDEN2
DANISH CANCER SOCIETY2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
INSTITUT GUSTAVE ROUSSY2
INSTITUT JULES BORDET2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
OSLO UNIVERSITETSSYKEHUS HF2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITY OF GLASGOW2
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACZON1
AQUAMARIJN MICRO FILTRATION BV1
ASPER BIOTECH1
ASTRAZENECA UK LIMITED1
BIOCHEMICAL INSTITUTE FOR ENVIRONMENTAL CARCINOGENS PROF DR GERNOT GRIMMER FOUNDATION1
CANCER RESEARCH UK1
CELENTYX LIMITED1
CENTRO SANA SERVIZI SANITARI PRIVATI1
DANAFARBER CANCER INSTITUTE INC NON PROFIT CORP DFCI1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECANCERMEDICALSCIENCE1
EUROPEAN CANCER ORGANISATION1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
FINNISH INSTITUTE OF OCCUPATIONAL HEALTH1
FOCUSED ULTRASOUND FOUNDATION1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION INSTITUTO VALENCIANO DE ONCOLOGIA1
GENETICS RESEARCH INSTITUTE ONLUS ASSOCIAZIONE1
GENEXPLAIN1
GENOME RESEARCH1
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT CURIE1
INSTITUT NATIONAL DU CANCER1
INSTITUTO TUMORI GIOVANNI PAOLO II1
INSTYTUT FARMACEUTYCZNY1
INTERNATIONAL PREVENTION RESEARCH INSTITUTE SAS1
ISTITUTO EUROPEO DI ONCOLOGIA1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI1
ISTITUTO ONCOLOGICO VENETO1
ISTITUTO ORTOPEDICO RIZZOLI1
JOHNS HOPKINS UNIVERSITY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LEOCORDIA AB1
LEUKOCARE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUNDS UNIVERSITET1
MAGYAR TUDOMANYOS AKADEMIA SZEGEDIBIOLOGIAI KUTATOKOZPONT1
NATIONAL HELLENIC RESEARCH FOUNDATION1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NETIX SKRZYPCZYNSKI KRZYSZTOFOWICZ SPOLKA JAWNA1
NOFER INSTITUTE OF OCCUPATIONAL MEDICINE1
ORBSEN THERAPEUTICS LIMITED1
ORSZAGOS KOZEGESZSEGUGYI KOZPONT1
ORSZAGOS ONKOLOGIAI INTEZET1
SKANE LANS LANDSTING1
SLOANKETTERING INSTITUTE FOR CANCER RESEARCH CORPORATION1
STICHTING ISALA KLINIEKEN1
THE CHRISTIE NHS FOUNDATION TRUST1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET BASEL1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE DE GENEVE1
UNIVERSITEIT MAASTRICHT1
UNIVERSITEIT TWENTE1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF LEICESTER1
UNIVERSITY OF WROCLAW1
UNIWERSYTET MIKOLAJA KOPERNIKA W TORUNIU1
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 106
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 97
Frequent / Rare Partner Ratio: 0.09

Project overview:

Start dateProjectacronymrolefundingpartners
2014-04-04CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer CDELPcoordinator231.2831
2013-10-01Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer LIVERNCODEcoordinator100.0002
2013-06-01Targeting microRNAs for ColoRectal Cancer Therapy TAMIRCRTcoordinator100.0002
2013-03-01Decision-making within cells and differentiation entity therapies DECIDEparticipant3.313.0228
2010-07-01Breast Cancer Somatic Genetics Study BASISparticipant10.499.99915

Alias institution names:

  • INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL